Stock A354390 BASKHANBIO PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Baskhanbio Pharma Inc.

Equities

A354390

KR7354390007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-20 pm EDT 		5-day change 1st Jan Change
6,360 KRW +0.16% Intraday chart for Baskhanbio Pharma Inc. -0.47% -6.47%

Business Summary

BaskhanBio Pharma Inc is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company is engaged in the manufacture and sale of antipyretic analgesic anti-inflammatory drugs, digestive system drugs, central nervous system drugs, nutritional supplements and other pharmaceuticals. In addition, the Company is engaged in the sale of medical devices and health functional foods.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Merchandise
59.6 %
17,630 65.8 % 18,119 59.6 % +2.78%
Refine - Antipyretic Analgesic and Anti-inflammatory Agent
10.7 %
2,492 9.3 % 3,261 10.7 % +30.85%
Refine - Other Drugs, Etc
7.5 %
1,502 5.6 % 2,276 7.5 % +51.57%
Refine - Other Digestive Medicines
5.9 %
1,560 5.8 % 1,808 5.9 % +15.86%
Hard - Antiepileptic Drugs
5.3 %
1,023 3.8 % 1,607 5.3 % +57.04%
Soft - Other Drugs, Etc
4.0 %
182 0.7 % 1,226 4.0 % +572.37%
Hard - Other Drugs, Etc
3.9 %
1,246 4.7 % 1,187 3.9 % -4.78%
Hard - Other Central Nervous System Drugs
3.0 %
862 3.2 % 920 3.0 % +6.74%
Soft - Other Nutritional Supplements
0.9 %
143 0.5 % 284 0.9 % +99.06%
Other
-0.9 %
109 0.4 % -265 -0.9 % -343.46%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
97.7 %
26,233 97.9 % 29,731 97.7 % +13.34%
International
2.3 %
565 2.1 % 692 2.3 % +22.50%

Managers

Managers TitleAgeSince
Beop-Pyo Lee CEO
 Chief Executive Officer 59 15-10-31

Members of the board

Members of the board TitleAgeSince
Beop-Pyo Lee CEO
 Chief Executive Officer 59 15-10-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,018,247 2,562,722 ( 36.52 %) 0 36.52 %

Shareholders

NameEquities%Valuation
Il-tae Jang
12.34 %
865,896 12.34 % 4 M ₩

Company contact information

BASKHANBIOpharma, Inc.

354 Wondang-ro Wongok-myeon

17557, Anseong-si

+

http://www.baskhanbio.com
address Baskhanbio Pharma Inc.(A354390)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
BASKHANBIO PHARMA INC. Stock Baskhanbio Pharma Inc.
-6.47% 32.11M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.63% 796B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.51% 628B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.10% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.95% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.66% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+3.39% 228B
NOVARTIS AG Stock Novartis AG
+10.75% 214B
AMGEN INC. Stock Amgen Inc.
+6.99% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A354390 Stock
  4. Company Baskhanbio Pharma Inc.